Compare HCA Health Inc (HCA) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs GeneDx Holdings Corp — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: HCA Health Inc is far larger — about 45.6× GeneDx Holdings Corp's market cap, and HCA Health Inc pays a 0.84% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| HCA | WGS | |
|---|---|---|
Market Cap | $82.17B | $1.80B |
Sector | Health | Technology |
52-Week High | $545.13 | $167.51 |
52-Week Low | $334.32 | $34.51 |
Enterprise Value | $131.08B | $1.80B |
Dividend Yield | 0.84% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
